##gff-version 3
##sequence-region Q9Y2K2 1 1321
Q9Y2K2	UniProtKB	Chain	1	1321	.	.	.	ID=PRO_0000252257;Note=Serine/threonine-protein kinase SIK3	
Q9Y2K2	UniProtKB	Domain	66	317	.	.	.	Note=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q9Y2K2	UniProtKB	Domain	344	384	.	.	.	Note=UBA;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00212	
Q9Y2K2	UniProtKB	Nucleotide binding	72	80	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q9Y2K2	UniProtKB	Compositional bias	2	54	.	.	.	Note=Ala-rich;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00001	
Q9Y2K2	UniProtKB	Compositional bias	650	1016	.	.	.	Note=Gln-rich;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00006	
Q9Y2K2	UniProtKB	Active site	188	188	.	.	.	Note=Proton acceptor;Ontology_term=ECO:0000255,ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159,ECO:0000255|PROSITE-ProRule:PRU10027	
Q9Y2K2	UniProtKB	Binding site	95	95	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q9Y2K2	UniProtKB	Modified residue	71	71	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19369195;Dbxref=PMID:19369195	
Q9Y2K2	UniProtKB	Modified residue	221	221	.	.	.	Note=Phosphothreonine%3B by LKB1;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:19369195,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:14976552;Dbxref=PMID:19369195,PMID:23186163,PMID:14976552	
Q9Y2K2	UniProtKB	Modified residue	469	469	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569,ECO:0000269|PubMed:29211348;Dbxref=PMID:23186163,PMID:24275569,PMID:29211348	
Q9Y2K2	UniProtKB	Modified residue	551	551	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19369195,ECO:0000244|PubMed:23186163;Dbxref=PMID:19369195,PMID:23186163	
Q9Y2K2	UniProtKB	Modified residue	591	591	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q6P4S6	
Q9Y2K2	UniProtKB	Modified residue	592	592	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q6P4S6	
Q9Y2K2	UniProtKB	Modified residue	626	626	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19369195,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:19369195,PMID:23186163,PMID:24275569	
Q9Y2K2	UniProtKB	Modified residue	647	647	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q6P4S6	
Q9Y2K2	UniProtKB	Modified residue	866	866	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19369195,ECO:0000244|PubMed:23186163;Dbxref=PMID:19369195,PMID:23186163	
Q9Y2K2	UniProtKB	Modified residue	978	978	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q9Y2K2	UniProtKB	Modified residue	986	986	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q6P4S6	
Q9Y2K2	UniProtKB	Alternative sequence	1	760	.	.	.	ID=VSP_059412;Note=In isoform 2. MAAAAASGAGGAAGAGTGGAGPAGRLLPPPAPGSPAAPAAVSPAAGQPRPPAPASRGPMPARIGYYEIDRTIGKGNFAVVKRATHLVTKAKVAIKIIDKTQLDEENLKKIFREVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGEIFDHLVAHGRMAEKEARRKFKQIVTAVYFCHCRNIVHRDLKAENLLLDANLNIKIADFGFSNLFTPGQLLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQNLRARVLSGKFRIPFFMSTECEHLIRHMLVLDPNKRLSMEQICKHKWMKLGDADPNFDRLIAECQQLKEERQVDPLNEDVLLAMEDMGLDKEQTLQSLRSDAYDHYSAIYSLLCDRHKRHKTLRLGALPSMPRALAFQAPVNIQAEQAGTAMNISVPQVQLINPENQIVEPDGTLNLDSDEGEEPSPEALVRYLSMRRHTVGVADPRTEVMEDLQKLLPGFPGVNPQAPFLQVAPNVNFMHNLLPMQNLQPTGQLEYKEQSLLQPPTLQLLNGMGPLGRRASDGGANIQLHAQQLLKRPRGPSPLVTMTPAVPAVTPVDEESSDGEPDQEAVQSSTYKDSNTLHLPTERFSPVRRFSDGAASIQAFKAHLEKMGNNSSIKQLQQECEQLQKMYGGQIDERTLEKTQQQHMLYQQEQHHQILQQQIQDSICPPQPSPPLQAACENQPALLTHQLQRLRIQPSSPPPNHPNNHLFRQPSNSPPPMSSAMIQPH->MACSTPHGSNRRLPRKCHFSLPTRTPTLCTSLRSVSPLCAGSQMGLRASRPSKLTWKKWATTAASNSCSRSVSSCRRCTGGRLMKEPWRRPSSSICYTSRSSTIKFSSNKFKTLSVLLSHLHLFRLHVKISQPSLPISSR	
Q9Y2K2	UniProtKB	Alternative sequence	365	412	.	.	.	ID=VSP_059413;Note=In isoform 4. Missing	
Q9Y2K2	UniProtKB	Alternative sequence	603	603	.	.	.	ID=VSP_059414;Note=In isoform 4. S->RYLANRSKRHTLAMTNPTAEIPPDLQRQLGQQPFRSRVWPPHLVPDQHR	
Q9Y2K2	UniProtKB	Alternative sequence	874	933	.	.	.	ID=VSP_059415;Note=In isoform 2 and isoform 4. Missing	
Q9Y2K2	UniProtKB	Alternative sequence	1171	1187	.	.	.	ID=VSP_059416;Note=In isoform 3. EPVIGNCMDRSSPGQAV->GKCLLTVEVLGQSALIN	
Q9Y2K2	UniProtKB	Alternative sequence	1188	1321	.	.	.	ID=VSP_059417;Note=In isoform 3. Missing	
Q9Y2K2	UniProtKB	Natural variant	389	389	.	.	.	ID=VAR_035634;Note=In a breast cancer sample%3B somatic mutation. H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs376144593,PMID:16959974	
Q9Y2K2	UniProtKB	Natural variant	1098	1098	.	.	.	ID=VAR_051662;Note=D->E;Dbxref=dbSNP:rs11216163	
Q9Y2K2	UniProtKB	Natural variant	1136	1136	.	.	.	ID=VAR_051663;Note=P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.6;Dbxref=dbSNP:rs12225230	
Q9Y2K2	UniProtKB	Natural variant	1161	1161	.	.	.	ID=VAR_035635;Note=In a breast cancer sample%3B somatic mutation. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
Q9Y2K2	UniProtKB	Mutagenesis	221	221	.	.	.	Note=Prevents phosphorylation and activation by STK11/LKB1 complex. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14976552;Dbxref=PMID:14976552	
Q9Y2K2	UniProtKB	Mutagenesis	469	469	.	.	.	Note=Loss of interaction with 14-3-3 proteins in response to cAMP signaling and%2C thus%2C still able to inhibit TORC activity. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29211348;Dbxref=PMID:29211348	
Q9Y2K2	UniProtKB	Mutagenesis	469	469	.	.	.	Note=Loss of interaction with 14-3-3 proteins in response to cAMP signaling and%2C thus%2C still able to inhibit TORC activity although not as strongly as the A-469. T->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29211348;Dbxref=PMID:29211348	
Q9Y2K2	UniProtKB	Mutagenesis	551	551	.	.	.	Note=Loss of interaction with 14-3-3 proteins in response to cAMP signaling and%2C thus%2C still able to inhibit TORC activity. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29211348;Dbxref=PMID:29211348	
Q9Y2K2	UniProtKB	Mutagenesis	551	551	.	.	.	Note=Loss of interaction with 14-3-3 proteins in response to cAMP signaling and%2C thus%2C still able to inhibit TORC activity. S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29211348;Dbxref=PMID:29211348	
Q9Y2K2	UniProtKB	Mutagenesis	626	626	.	.	.	Note=No effect on interaction with 14-3-3 proteins. No effect on regulation in response to cAMP signaling. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29211348;Dbxref=PMID:29211348	
Q9Y2K2	UniProtKB	Mutagenesis	626	626	.	.	.	Note=No effect on regulation in response to cAMP signaling. S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29211348;Dbxref=PMID:29211348	
